BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20182397)

  • 1. Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment.
    Kim HM; Chung MJ; Chung JB
    Pancreas; 2010 Jul; 39(5):555-60. PubMed ID: 20182397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome.
    Kamisawa T; Okamoto A; Wakabayashi T; Watanabe H; Sawabu N
    Scand J Gastroenterol; 2008; 43(5):609-13. PubMed ID: 18415756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of swollen duodenal papilla in autoimmune pancreatitis.
    Kubota K; Iida H; Fujisawa T; Ogawa M; Inamori M; Saito S; Kakuta Y; Oshiro H; Nakajima A
    Pancreas; 2007 Nov; 35(4):e51-60. PubMed ID: 18090232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune pancreatitis.
    Detlefsen S; Drewes AM
    Scand J Gastroenterol; 2009; 44(12):1391-407. PubMed ID: 19958057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.
    Kubota K; Iida H; Fujisawa T; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Saito S; Ohshiro H; Kakuta Y; Nakajima A
    Gastrointest Endosc; 2007 Dec; 66(6):1142-51. PubMed ID: 18061714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis.
    Sah RP; Chari ST; Pannala R; Sugumar A; Clain JE; Levy MJ; Pearson RK; Smyrk TC; Petersen BT; Topazian MD; Takahashi N; Farnell MB; Vege SS
    Gastroenterology; 2010 Jul; 139(1):140-8; quiz e12-3. PubMed ID: 20353791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prognosis of duct-narrowing chronic pancreatitis: strategy for steroid treatment.
    Wakabayashi T; Kawaura Y; Satomura Y; Watanabe H; Motoo Y; Sawabu N
    Pancreas; 2005 Jan; 30(1):31-9. PubMed ID: 15632697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary tract involvement in autoimmune pancreatitis.
    Nishino T; Toki F; Oyama H; Oi I; Kobayashi M; Takasaki K; Shiratori K
    Pancreas; 2005 Jan; 30(1):76-82. PubMed ID: 15632703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in autoimmune pancreatitis.
    Park DH; Kim MH; Chari ST
    Gut; 2009 Dec; 58(12):1680-9. PubMed ID: 19240063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune pancreatitis: current concepts.
    Wang Q; Zhang X; Zhang F
    Sci China Life Sci; 2013 Mar; 56(3):246-53. PubMed ID: 23526391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Japanese diagnostic criteria for autoimmune chronic pancreatitis: is it completely satisfactory?
    Choi EK; Kim MH; Kim JC; Han J; Seo DW; Lee SS; Lee SK
    Pancreas; 2006 Jul; 33(1):13-9. PubMed ID: 16804407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic strategy for autoimmune pancreatitis.
    Kamisawa T; Satake K
    Adv Med Sci; 2008; 53(2):145-8. PubMed ID: 18762470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance.
    Deshpande V; Gupta R; Sainani N; Sahani DV; Virk R; Ferrone C; Khosroshahi A; Stone JH; Lauwers GY
    Am J Surg Pathol; 2011 Jan; 35(1):26-35. PubMed ID: 21164284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune pancreatitis: an update.
    Sugumar A; Chari S
    Expert Rev Gastroenterol Hepatol; 2009 Apr; 3(2):197-204. PubMed ID: 19351289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune chronic pancreatitis.
    Kim KP; Kim MH; Song MH; Lee SS; Seo DW; Lee SK
    Am J Gastroenterol; 2004 Aug; 99(8):1605-16. PubMed ID: 15307882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in autoimmune pancreatitis: type 1 and type 2.
    Kamisawa T; Chari ST; Lerch MM; Kim MH; Gress TM; Shimosegawa T
    Gut; 2013 Sep; 62(9):1373-80. PubMed ID: 23749606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune pancreatitis with multifocal lesions.
    Kajiwara M; Kojima M; Konishi M; Nakagohri T; Takahashi S; Gotohda N; Hasebe T; Ochiai A; Kinoshita T
    J Hepatobiliary Pancreat Surg; 2008; 15(4):449-52. PubMed ID: 18670850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis.
    Sandanayake NS; Church NI; Chapman MH; Johnson GJ; Dhar DK; Amin Z; Deheragoda MG; Novelli M; Winstanley A; Rodriguez-Justo M; Hatfield AR; Pereira SP; Webster GJ
    Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1089-96. PubMed ID: 19345283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document.
    Chari ST; Kloeppel G; Zhang L; Notohara K; Lerch MM; Shimosegawa T;
    Pancreas; 2010 Jul; 39(5):549-54. PubMed ID: 20562576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic retroperitoneal fibrosis associated with IgG4-positive-plasmacyte infiltrations and idiopathic chronic pancreatitis.
    Miyajima N; Koike H; Kawaguchi M; Zen Y; Takahashi K; Hara N
    Int J Urol; 2006 Nov; 13(11):1442-4. PubMed ID: 17083400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.